Enokizumab (MEDI-528) is a моноклональный антитело targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast клетка numbers and activity in the airways.
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.